Enhancing 3D Disease Models

Improving lab scalability for advanced drug discovery

There’s a critical need in advanced drug discovery and development for biological model systems that better resemble human biology. Most organ-on-a-chip (OoC) technologies are either based on a single or small number of culture chips and may not be compatible with high-content imagers - limiting their scalability and thus their utility for drug discovery studies. Until now.

In this webinar we explore how OoC technology provides insights into normal human organ function and disease pathophysiology, and more accurately predicts the safety and efficacy of investigational drugs in humans.